Back to search

Article

No gender differences in the 24 month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

2023-12-02

Abstract excerpt

<h4>Purpose: </h4> Untreated HCV mono and HCV/HIV coinfected women have lower degrees of liver fibrosis (LF) compared to men. Direct acting antiviral (DAA) therapy attains viral eradication in > 90% of patients with progressive LF decline in parallel. Gender-related differences in LF regression in the long term assessed by non-invasive liver fibrosis markers (NILFM) in HCV mono and HCV/HIV coinfected after DAA tre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc474f4a-fbb3-50dd-b147-45e5ff2ed9f8
DOI
10.21203/rs.3.rs-3650739/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
No gender differences in the 24 month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapyDOI 10.21203/rs.3.rs-3650739/v1
Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.Semantic proximity
Plasma TIMP-1 is a Useful Tool for Monitoring 24 Months Liver Fibrosis Improvement After Anti-HCV /DAA Therapy in HCV/HIV Mono/CoinfectionSemantic proximity
Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting AntiviralsSemantic proximity
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis.Semantic proximity
Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.Semantic proximity
HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.Semantic proximity
Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.Semantic proximity
Improvement of liver disease and inflammation in patients with advanced HCV-related cirrhosis after antiviral therapySemantic proximity
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.Semantic proximity
Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.Semantic proximity
There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.Semantic proximity
Sustained virological response according to the type of early virological response in HCV and HCV/HIV.Semantic proximity
Select a neighboring publication to make it the new centre.